Literature DB >> 7686710

Colloid osmotic pressure of plasma replacement fluids.

T Tønnessen1, S Tølløfsrud, U E Kongsgaard, H Noddeland.   

Abstract

Colloid osmotic pressure (COP) of some of the most frequently used plasma replacement fluids was measured with a colloid osmometer. COP of 4% human albumin solutions was only half that of normal human serum (13.6 +/- 0.6 vs. 27.5 +/- 2.7 mmHg (1.8 +/- 0.1 vs. 3.7 +/- 0.4 kPa)) (mean +/- s.d.), whereas COP of 20% human albumin solutions was eight times higher (196.0 +/- 12.3 mmHg (26.1 +/- 1.6 kPa)). Enhancing the protein concentration from 4% to 20% in the human albumin solutions increased COP 14-fold, reflecting the exponential relationship between protein concentration and COP of a solution. Fresh donor plasma furnished by the hospital blood-bank had a COP about 30% below normal human serum (18.1 +/- 1.3 mmHg (2.4 +/- 0.2 kPa)), due to dilution during preparation. Dextran 70 (6%) had a COP more than twice, and Ringer-Dextran 60 (3%) about 75% of that of normal human serum. Dextran 40 (10%) and gelatin (3.5%, Haemaccel) leaked markedly through the membrane of the colloid osmometer, making acceptable measurements impossible. Seven different hydroxyethyl starch (HES) solutions were measured, and the COP varied between half and 3 times that of normal human serum, depending on molecular weight and concentration of the HES.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686710     DOI: 10.1111/j.1399-6576.1993.tb03741.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

1.  Resuscitation with hyperoncotic colloids in the intensive care unit.

Authors:  Christian J Wiedermann
Journal:  Intensive Care Med       Date:  2008-12-24       Impact factor: 17.440

2.  Transvascular fluid distribution of hyperoncotic Dextran solution.

Authors:  Kiyoshi Horiba; Yoshiaki Takumi; Mitiharu Kandori; Yasusuke Inoue; Hiroshi Noguchi
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

3.  Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial.

Authors:  Thiemo F Veneman; Jeroen Oude Nijhuis; Arend J J Woittiez
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

4.  Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?

Authors:  Chiedozie I Udeh; Jing You; Matthew R Wanek; Jarrod Dalton; Belinda L Udeh; Sevag Demirjian; Nadeem Rahman; J Steven Hata
Journal:  Perioper Med (Lond)       Date:  2018-12-14

5.  Exploring how plasma- and muscle-related parameters affect trout hemolysis as a route to prevent hemoglobin-mediated lipid oxidation of fish muscle.

Authors:  Semhar Ghirmai; Haizhou Wu; Michael Axelsson; Takashi Matsuhira; Hiromi Sakai; Ingrid Undeland
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

6.  Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials.

Authors:  Christian J Wiedermann; Stefan Dunzendorfer; Luigi U Gaioni; Francesco Zaraca; Michael Joannidis
Journal:  Crit Care       Date:  2010-10-28       Impact factor: 9.097

7.  Colloid osmotic pressure of contemporary and novel transfusion products.

Authors:  Robert B Klanderman; Joachim J Bosboom; Herbert Korsten; Thomas Zeiler; Ruben E A Musson; Denise P Veelo; Bart F Geerts; Robin van Bruggen; Dirk de Korte; Alexander P J Vlaar
Journal:  Vox Sang       Date:  2020-05-06       Impact factor: 2.144

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.